Establishes an Alzheimer's disease outreach and education program

2025 Regular Session Introduced by Nader Sayegh

Creates a state Alzheimer’s disease outreach and education program to inform the public about Alzheimer’s, resources, and care options.

SIGNED CHAP.47

What the bill would do

Establishes a state-level Alzheimer’s disease outreach and education program. The primary aim is to create organized efforts to inform the public about Alzheimer’s disease, including awareness, education, and related resources.

Note: The available information confirms the bill’s broad purpose to establish an outreach and education program, but the specific program structure, activities, and administration are not detailed in the material provided.

Legislative status and timeline

Introduced: January 9, 2025

Passed Assembly: January 27, 2025

Delivered to Senate: January 27, 2025

Passed Senate: February 10, 2025

Delivered to Governor: February 12, 2025

Signed into law (Chapter 47): February 14, 2025

Related bill: S 2669 (companion in the Senate). The companion indicates cross-chamber consideration and potential alignment between the chambers.

Key provisions (as stated)

The central provision is the creation of an Alzheimer's disease outreach and education program. The text provided does not include detailed statutory language on:

The administering agency or department
Funding sources or amounts
Specific activities (materials development, training, community partnerships, caregiver resources, etc.)
Reporting, evaluation, or performance metrics
Implementation timelines or sunset provisions

Who would be affected

Individuals living with Alzheimer’s disease and their families/caregivers

Healthcare and social service providers, aging services organizations, and community groups involved in outreach and education

Public health and aging-focused agencies responsible for implementing or coordinating the program

Administrative and timeline considerations

With the bill now enacted as Chapter 47, the program would be established as a state effort; however, implementation details (such as which agency leads the program, how it’s funded, and the initial actions to roll out outreach) would be defined in the bill’s text or in subsequent regulations and guidance.

Potentially, the program could involve partnerships with healthcare providers, community organizations, and educational institutions to disseminate information about Alzheimer’s disease, symptoms, early detection, care options, and available resources.

Observations

The bill’s life cycle shows rapid passage through both chambers and swift enactment, reflecting legislative priority on Alzheimer’s disease outreach.

The companion Senate bill (S 2669) suggests alignment across chambers and indicates the core policy goal is shared in both houses.

For readers seeking details on specific program components, funding levels, or implementation timelines, reviewing the enacted Chapter 47 text and any related regulatory guidance will provide the precise provisions.

Bill